<DOC>
	<DOCNO>NCT00570752</DOCNO>
	<brief_summary>The purpose study determine whether p38 kinase inhibitor reduce inflammation atherosclerotic plaque</brief_summary>
	<brief_title>Efficacy Study p38 Kinase Inhibitor Treat Patients With Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>History document atherosclerosis LDL 70 130 mg/dL Patients receive stable low moderatedose statin BMI 1837 kg/mÂ² Must able swallow tablet Must able medically tolerate procedure , contrast medium , medication involve Statin intolerance Renal impairment ( serum creatinine &gt; 1.5 mg/dL ) History chronic viral hepatitis liver dysfunction Major infection require hospitalization receipt IV antibiotic due infection within 2 month prior initiation study treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>